Nova Max Plus incorporates advanced technology for accurate and precise self-monitoring of blood glucose and ketones by people with diabetes. Nova Max Plus has the most comprehensive features for fast, easy, and error-free blood glucose and ketone monitoring.

Glucose and Ketones on the Same Monitor

The Nova Max Plus Glucose Meter automatically converts itself to a Ketone meter by inserting the Nova Max Plus Ketone strip.

Why Ketone Measurements Are Important

Diabetic Ketoacidosis (DKA) is a life-threatening metabolic complication of diabetes with a mortality rate of 2%-10% 1

DKA is the leading cause of hospitalization, morbidity, and death in children with Type 1 diabetes 2

The use of a blood test for early detection of increased blood ketone levels can help to avert DKA 3,4,5

According to the ADA, blood ketone testing should be performed on sick days and whenever glucose is greater than 250-300 mg/dL.

No Coding Needed

Miscoded meters can lead to glucose errors as large as 50%

No Maltose Error

Keeps some patients from getting falsely elevated glucose results from the presence of other sugars in the blood such as maltose.

Tiny 0.3 Microliter Sample Size

Less pain for patients.

Thin 33 Gauge Lancets

Thinnest on the market – virtually pain free lancing –especially important for patients who test frequently.

Fast 5-Second Glucose Results and 10-Second Ketone Results

Alternate Site glucose Testing

The Best Overall Glucose Meter

For more information on the Nova Max Plus meter visit www.novacares.com

* Based on lancets included with the featured glucose monitoring systems.

** On August 13, 2009 the FDA advised healthcare facilities to avoid using glucose test strips with GDH-PQQ enzyme.
The FDA advisory notice reported 13 patient deaths caused by interference from maltose and other non-glucose sugars. Source: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm176992.htm.

1 Laffel L. Endocrinol Metab Clin North Am 2000;29:707-723.

2 Casteels K et al. Rev Endoc Metab Disord 2003;4(2):159-166.

3 Laffel LM et al. Diabet Med 2005;23(3):278-284.

4 Umpierrex GE et al. Treat Endocrinol 2003;2(2):95-108.

5 Guerci B et al. Diabetes Metab 2005;31:401-406.